Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 1,453 shares at $395.28 ($573K) on 2020-09-14, disclosed to the SEC on 2020-09-16.
Open-market sale of $573k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $386.21 | 3 | $1K | 0.2% |
| 2 | $390.86 | 109 | $43K | 7.4% |
| 3 | $391.95 | 200 | $78K | 13.7% |
| 4 | $393.73 | 231 | $91K | 15.9% |
| 5 | $393.73 | 231 | $91K | 15.9% |
| 6 | $395.28 | 222 |
| $88K |
| 15.3% |
| 7 | $395.28 | 222 | $88K | 15.3% |
| 8 | $396.17 | 121 | $48K | 8.4% |
| 9 | $397.75 | 114 | $45K | 7.9% |
| Total | $394.25 avg | 1,453 | $573K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |